الصفحة الرئيسية>>Lipids>> Glycerophospholipids>>1-1(Z)-Hexadecenyl-2-Palmitoyl-sn-glycero-3-PC

1-1(Z)-Hexadecenyl-2-Palmitoyl-sn-glycero-3-PC (Synonyms: C16(plasm)-16:0-PC, 16:0p/16:0-PC, PC(P-16:0/16:0), 1-1(Z)-Hexadecenyl-2-Hexadecanoyl-sn-glycero-3-Phosphatidylcholine, 1-1(Z)-Hexadecenyl-2-Hexadecanoyl-sn-glycero-3-Phosphocholine)

رقم الكتالوجGC45708

A plasmalogen

Products are for research use only. Not for human use. We do not sell to patients.

1-1(Z)-Hexadecenyl-2-Palmitoyl-sn-glycero-3-PC التركيب الكيميائي

Cas No.: 126901-45-9

الحجم السعر المخزون الكميّة
500μg
170٫00
متوفر
1mg
321٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

1-1(Z)-Hexadecenyl-2-palmitoyl-sn-glycero-3-PC is a plasmalogen that has been found in various rat tissues, including the liver, heart, kidney, gluteus muscle, soleus muscle, and visceral and subcutaneous adipose tissue.1 It has been used in the synthesis of lipid bilayers to quantify the effects of amphiphilic compounds, such as lysophosphatidylcholine and lysoplasmenylcholine, on membrane dynamics.2

|1. Pradas, I., Huynh, K., CabrÉ, R., et al. Lipidomics reveals a tissue-specific fingerprint. Front. Physiol. 9, 1165 (2018).|2. Han, X., and Gross, R.W. Alterations in membrane dynamics elicited by amphiphilic compounds are augmented in plasmenylcholine bilayers. Biochim. Biophys. Acta. 1069(1), 37-45 (1991).

مراجعات

Review for 1-1(Z)-Hexadecenyl-2-Palmitoyl-sn-glycero-3-PC

Average Rating: 5 ★★★★★ (Based on Reviews and 26 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 1-1(Z)-Hexadecenyl-2-Palmitoyl-sn-glycero-3-PC

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.